Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Vicente Valero, MD
Date of Release
May 14th, 2025
